Series E Financing Reflects Sustained Investor Confidence in CeQur's Commercial Trajectory, Clinical Results, and Growing Demand for a Simpler Approach to Mealtime Insulin. Horw, Switzerland – June 9, 2026 – CeQur®, the company dedicated to simplifying mealtime insulin delivery for people living with diabetes, today announced the close of a [...]
Extended 7-Day Wear and 1-Unit Dosing Clearances, and Two ADA Posters Signal a New Standard for Mealtime Insulin Management. HORW, Switzerland, June 4, 2026 /PRNewswire/ – CeQur®, the company dedicated to simplifying mealtime insulin delivery for people living with diabetes, today announced two recent FDA clearances for CeQur Simplicity™: extended [...]
Patrick McBrayer Stepping Down Following Transformative Tenure That Positioned Company for Next Phase of Growth WESTBOROUGH, Massachusetts – May 11, 2026 – Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced Jamal [...]
6x Higher Rate of Post-Traumatic Osteoarthritis (PTOA) for ACL Reconstruction Compared to BEAR Implant Observed in BEAR I and II Studies WESTBOROUGH, Massachusetts – January 14, 2026 – Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears, today announced that the U.S. Food and [...]
Acquisition to expand the neuromodulation offerings for people living with chronic pain. MARLBOROUGH, Mass., Oct. 17, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held medical technology company focused on developing and commercializing innovative [...]
Seasoned medtech leader and former Intuitive Surgical executive to accelerate development and commercialization of the company's next-generation MIRA Surgical System platform and technologies LINCOLN, Neb. – June 18, 2025 – Virtual Incision Corporation the developer of the MIRA Surgical System authorized by the FDA through the De Novo regulatory pathway, [...]
Sudden Cardiac Arrest (SCA) is a life-threatening condition affecting hundreds of thousands of individuals each year, particularly those with low Left Ventricular Ejection Fraction (LVEF). While wearable cardioverter defibrillators (WCDs) are a well-established therapy for preventing SCA, adherence rates are often low. Kestra Medical Technologies is tackling this issue with [...]
Kestra Medical Technologies Ltd., a prominent name in the wearable medical devices sector, has officially filed for an initial public offering (IPO), showcasing a remarkable surge in revenue that has nearly tripled. The Bloomberg report highlights that the company is poised to offer new shares as part of this financial [...]
The financing secured will drive growth and accelerate commercial expansion efforts, support the scaling of commercial teams and outreach initiatives to bring CeQur Simplicity™, its 4-day wearable insulin delivery device, to more healthcare providers and patients managing diabetes. Horw, Switzerland, January 7, 2025 – CeQur®, a medical device company dedicated [...]
In the United States alone, an estimated 10-12 million adults live with moderate to severe chronic neuropathic pain. The effects can be debilitating, leading not only to extreme physical discomfort, but also psychological distress, social isolation, reduced worker productivity and an overall decrease in quality of life. [...]